These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 34612310)

  • 1. 2,2'-Bipyrimidine-based luminescent Ru(ii)/Ir(iii)-arene monometallic and homo- and hetero-bimetallic complexes for therapy against MDA-MB-468 and caco-2 cells.
    Roy N; Sen U; Moharana P; Babu LT; Kar B; Vardhan S; Sahoo SK; Bose B; Paira P
    Dalton Trans; 2021 Sep; 50(34):11725-11729. PubMed ID: 34612310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria-Targeting Click-Derived Pyridinyltriazolylmethylquinoxaline-Based Y-Shaped Binuclear Luminescent Ruthenium(II) and Iridium(III) Complexes as Cancer Theranostic Agents.
    Roy N; Sen U; Madaan Y; Muthukumar V; Varddhan S; Sahoo SK; Panda D; Bose B; Paira P
    Inorg Chem; 2020 Dec; 59(23):17689-17711. PubMed ID: 33210921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Half-sandwich Ru(η
    Huang YC; Haribabu J; Chien CM; Sabapathi G; Chou CK; Karvembu R; Venuvanalingam P; Ching WM; Tsai ML; Hsu SCN
    J Inorg Biochem; 2019 May; 194():74-84. PubMed ID: 30831392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands.
    Nikolić S; Rangasamy L; Gligorijević N; Aranđelović S; Radulović S; Gasser G; Grgurić-Šipka S
    J Inorg Biochem; 2016 Jul; 160():156-65. PubMed ID: 26818702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and cytotoxic activities of organometallic Ru(II) diamine complexes.
    Kavukcu SB; Şahin O; Seda Vatansever H; Kurt FO; Korkmaz M; Kendirci R; Pelit L; Türkmen H
    Bioorg Chem; 2020 Jun; 99():103793. PubMed ID: 32278205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity of Ru(II) piano-stool complexes with chloroquine and chelating ligands against breast and lung tumor cells: Interactions with DNA and BSA.
    Colina-Vegas L; Villarreal W; Navarro M; de Oliveira CR; Graminha AE; Maia PIDS; Deflon VM; Ferreira AG; Cominetti MR; Batista AA
    J Inorg Biochem; 2015 Dec; 153():150-161. PubMed ID: 26277415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuning the cytotoxicity of ruthenium(ii) para-cymene complexes by mono-substitution at a triphenylphosphine/phenoxydiphenylphosphine ligand.
    Biancalana L; Zacchini S; Ferri N; Lupo MG; Pampaloni G; Marchetti F
    Dalton Trans; 2017 Dec; 46(47):16589-16604. PubMed ID: 29164209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bipyrimidine-Bridged Mixed-Metal Trimetallic Complexes of Ruthenium(II) with Rhodium(III) or Iridium(III), {[(bpy)(2)Ru(bpm)](2)MCl(2)}(5+).
    Nallas GN; Jones SW; Brewer KJ
    Inorg Chem; 1996 Nov; 35(24):6974-6980. PubMed ID: 11666875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G2/M-Phase-Inhibitory Mitochondrial-Depolarizing Re(I)/Ru(II)/Ir(III)-2,2'-Bipyrimidine-Based Heterobimetallic Luminescent Complexes: An Assessment of In Vitro Antiproliferative Activity and Bioimaging for Targeted Therapy toward Human TNBC Cells.
    Roy N; Shanavas S; Kar B; Thilak Babu L; Das U; Vardhan S; Sahoo SK; Bose B; Rajagopalan V; Paira P
    ACS Omega; 2023 Apr; 8(13):12283-12297. PubMed ID: 37033791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization, HSA/DNA interactions and antitumor activity of new [Ru(η
    Đukić MB; Jeremić MS; Filipović IP; Klisurić OR; Kojić VV; Jakimov DS; Jelić RM; Onnis V; Matović ZD
    J Inorg Biochem; 2020 Dec; 213():111256. PubMed ID: 32980642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, chemical characterization, PARP inhibition, DNA binding and cellular uptake of novel ruthenium(II)-arene complexes bearing benzamide derivatives in human breast cancer cells.
    Pavlović M; Tadić A; Gligorijević N; Poljarević J; Petrović T; Dojčinović B; Savić A; Radulović S; Grgurić-Šipka S; Aranđelović S
    J Inorg Biochem; 2020 Sep; 210():111155. PubMed ID: 32768729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of the Microtubule Network and Inhibition of VEGFR2 Phosphorylation by Cytotoxic
    Acharya S; Maji M; Chakraborty MP; Bhattacharya I; Das R; Gupta A; Mukherjee A
    Inorg Chem; 2021 Mar; 60(5):3418-3430. PubMed ID: 33554592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.
    Dougan SJ; Melchart M; Habtemariam A; Parsons S; Sadler PJ
    Inorg Chem; 2006 Dec; 45(26):10882-94. PubMed ID: 17173447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of
    Mukherjee A; Acharya S; Purkait K; Chakraborty K; Bhattacharjee A; Mukherjee A
    Inorg Chem; 2020 May; 59(9):6581-6594. PubMed ID: 32295347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of high in vitro and in vivo antitumor activities of organometallic ruthenium(ii)-arene complexes with 5,7-dihalogenated-2-methyl-8-quinolinol.
    Meng T; Qin QP; Chen ZL; Zou HH; Wang K; Liang FP
    Dalton Trans; 2019 Apr; 48(16):5352-5360. PubMed ID: 30942794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA targeting half sandwich Ru(II)-
    Mondal A; Sen U; Roy N; Muthukumar V; Sahoo SK; Bose B; Paira P
    Dalton Trans; 2021 Jan; 50(3):979-997. PubMed ID: 33355328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent Inhibition of Thioredoxin Reductase by the Rh Derivatives of Anticancer M(arene/Cp*)(NHC)Cl
    Truong D; Sullivan MP; Tong KKH; Steel TR; Prause A; Lovett JH; Andersen JW; Jamieson SMF; Harris HH; Ott I; Weekley CM; Hummitzsch K; Söhnel T; Hanif M; Metzler-Nolte N; Goldstone DC; Hartinger CG
    Inorg Chem; 2020 Mar; 59(5):3281-3289. PubMed ID: 32073260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-targeting organometallic ruthenium(II) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands.
    Zhang Y; Zheng W; Luo Q; Zhao Y; Zhang E; Liu S; Wang F
    Dalton Trans; 2015 Aug; 44(29):13100-11. PubMed ID: 26106875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, characterization, antimicrobial and cytotoxic activity of novel half-sandwich Ru(II) arene complexes with benzoylthiourea derivatives.
    Obradović D; Nikolić S; Milenković I; Milenković M; Jovanović P; Savić V; Roller A; Đorđić Crnogorac M; Stanojković T; Grgurić-Šipka S
    J Inorg Biochem; 2020 Sep; 210():111164. PubMed ID: 32634653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.